Comparative analyses of structural features and scaffold diversity for purchasable compound libraries.

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Drug Discovery

Background:

• Purchasable small molecule screening libraries are vital for virtual screening (VS) in drug discovery.
• Selecting optimal libraries improves VS success rates and conserves resources.
• Understanding library structural features and diversity aids informed selection.

Purpose of the Study:

• To analyze and compare the structural features and scaffold diversity of eleven commercial screening libraries and the Traditional Chinese Medicine Compound Database (TCMCD).
• To provide insights for selecting appropriate screening libraries for virtual screening campaigns.

Main Methods:

• Analysis of structural features and molecular diversity using Murcko frameworks and Level 1 scaffolds.
• Characterization of scaffold diversity via scaffold counts and cumulative frequency plots.
• Visualization of diversity using Tree Maps and SAR Maps.

Main Results:

• Chembridge, ChemicalBlock, Mucle, TCMCD, and VitasM exhibited higher structural diversity on standardized subsets.
• TCMCD showed high structural complexity but more conservative molecular scaffolds compared to commercial libraries.
• Identified pharmacologically important scaffolds in libraries as potential inhibitors for targets like kinases and GPCRs.

Conclusions:

• The study provides a valuable perspective on selecting diverse and relevant compound libraries for virtual screening.
• Scaffold analysis is a key strategy for evaluating and choosing screening libraries.
• Findings can guide researchers in optimizing library selection for specific drug discovery projects.